India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...
Chimerix Inc (NASDAQ: NASDAQ:CMRX) stock has reached a new 52-week high, touching the $4.3 mark, signaling a significant ...
CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC in ESMO guideline: Suzhou, China Tuesday, February 11, 2025, 13:00 Hrs [IST] CStone Phar ...
Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...
Shocking epiphany? The sun’s alignment with Mercury brings hidden information to light. And just in time! You were on the brink of making a defining financial or business move. Today’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results